BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4248282)

  • 1. Some theoretical considerations on chalones and the treatment of cancer: a review.
    Iversen OH
    Cancer Res; 1970 May; 30(5):1481-4. PubMed ID: 4248282
    [No Abstract]   [Full Text] [Related]  

  • 2. The chalones: a review.
    Bullough WS
    Natl Cancer Inst Monogr; 1973 Jul; 38():5-16. PubMed ID: 4271052
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chalones. Endogenous inhibitors of cell division?].
    Paukovits WR
    Blut; 1973 Oct; 27(4):217-22. PubMed ID: 4275334
    [No Abstract]   [Full Text] [Related]  

  • 4. The actions of the chalones.
    Bullough WS
    Agents Actions; 1971 Apr; 2(1):1-7. PubMed ID: 4256925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of chalones in the therapy of leukemias].
    Bala IuM; Kovalevskaia NP
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):12-6. PubMed ID: 6460236
    [No Abstract]   [Full Text] [Related]  

  • 6. Chalone control mechanisms.
    Bullough WS
    Life Sci; 1975 Feb; 16(3):323-30. PubMed ID: 123999
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of cell production by chalones.
    Rytömaa T
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):94-5. PubMed ID: 4247454
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of tissue extracts in the treatment of cancer].
    Mohr U
    Langenbecks Arch Chir; 1971 Dec; 329():275-86. PubMed ID: 4349142
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antitumor activity of tumor necrosis factor (TNF) in vitro and in vivo].
    Haranaka K; Satomi N; Sakurai A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1387-93. PubMed ID: 6742865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukins, interferons and tumor necrosis factor in cancer treatment.
    Krigel RL
    AAOHN J; 1987 Apr; 35(4):159-62. PubMed ID: 2950885
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chalones and tumor growth].
    Okulov VB
    Vopr Onkol; 1981; 27(4):101-14. PubMed ID: 6453470
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chalones in the epidermis of the mouse].
    Guigon M; Frindel E; Hewitt J; Tubiana M
    Ann Dermatol Syphiligr (Paris); 1973; 100(3):279-82. PubMed ID: 4274610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidermial chalone of human skin. Review of the literature and experimental contribution (author's transl)].
    Bassi AM; Burlando F; Romano S; Ferro M
    Pathologica; 1980; 72(1018):201-18. PubMed ID: 6450394
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of chalones produced by a primary tumor in the blood of mice with Lewis carcinoma].
    Sopotsinskaia EB; Fadeev VA; Balitskiĭ KP
    Eksp Onkol; 1984; 6(3):42-4. PubMed ID: 6238816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chalones.
    Iversen OH
    Acta Pathol Microbiol Scand Suppl; 1973; 236():71-6. PubMed ID: 4272767
    [No Abstract]   [Full Text] [Related]  

  • 16. Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?
    Donelli A; Chiodino C; Panissidi T; Roncaglia R; Torelli G
    Haematologica; 2000 Sep; 85(9):1002-3. PubMed ID: 10980650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytostatic treatment with the streptomyces extract mitomycin].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1968 Jan; 118(2):29-32. PubMed ID: 5243841
    [No Abstract]   [Full Text] [Related]  

  • 18. The pattern of tumour growth.
    Bullough WS; Deol JU
    Symp Soc Exp Biol; 1971; 25():255-75. PubMed ID: 4256515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Purification of epidermal G2-chalone using immunoaffinity chromatography].
    Ketlinskiĭ SA; Simbirtsev AS
    Biull Eksp Biol Med; 1983 Aug; 96(8):71-3. PubMed ID: 6224519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The control of mitosis by chalones].
    Rytömaa T
    Duodecim; 1970; 86(2):75-7. PubMed ID: 4245811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.